Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Tracing STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition×Refreshed just now
All24 hours
× Show allIn focus

Senate weighs vote to block US-Saudi civil nuclear agreement

The August 2026 U.S.-Saudi Section 123 agreement is under congressional review, which CRS says may end in December 2026. Senate Foreign Relations scheduled a closed briefing on Nov. 17, and a possible Senate vote on blocking the pact is in view as Houthi attacks on Saudi infrastructure add scrutiny. IAEA chief Rafael Grossi called the inspection terms satisfactory without the Additional Protocol, while nonproliferation critics remain opposed. · yesterday

Forces, money & more Energy

Activity · 30 days back, 14 ahead

Total
5
Peak/day
2Nov 17
7d
5▲5
Next
—
Σ/day2
Hill3
Contracts0
News2

In the News

One card per story, every outlet that covered it
20
  1. 4d agoYahooWhite House pulls FDA nominee Heidi Overton after wavering support from Senate RepublicansSTAT's Readout Loud podcast episode covers the Trump administration withdrawing Heidi Overton's FDA commissioner nomination, the FDA's rejection of Summit Therapeutics and Akeso's lung cancer drug, and STAT's new index ranking China's largest drugmakers.
    4 articles · 2 outlets
    1. 4d agoSTATSTAT+: White House pulls nomination of Heidi Overton to lead FDA
    2. 4d agoYahooPickupWhite House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
    3. 3d agoSTATSTAT+: 7 burning questions about the FDA’s post-Overton future
    4. 2d agoSTATEarliestFDA’s search for a new leader, and China’s largest drugmakers
    Biotech66 linked
  2. 2d agoSTATSTAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaThis STAT Pharmalittle roundup notes that major pharmaceutical firms are using AI for molecule design and early-stage work, and that several large drugmakers pledged to the House China committee to avoid new Xinjiang and military-affiliated trial sites.
    2 articles
    1. 2d agoSTATSTAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China
    2. 2d agoSTATEarliestSTAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more
    Biotech17 linked
  3. 10d agoYahooAre Our Medical Supplies Safe From Cyberattacks? What France’s Blood Bank Hack Means For The U.S.France's foreign minister says Paris may impose measures on Iran over alleged hacking of supermarket freezers and blood bank cold storage, and has summoned Iran's ambassador.
    6 articles · 4 outlets · TechCrunch
    1. 12d agoYahooPickupFrance blames Iran for cyberattacks on supermarket cooling systems
    2. 12d agoTechCrunchPickupFrance blames Iran for mass-hacks targeting freezers in grocery stores and blood banks
    3. 12d agoYahooPickupFrance Blames Iran For Cyberattack That Heated Supermarket Refrigerators—Causing Millions In Damage
    4. 12d agoAl JazeeraPickupWhat is Shahid Kaveh, ⁠⁠the Iran cyberunit tied to France’s fridge hacking?
    5. 12d agoThe Associated PressEarliestFrance Believes Iran Was Behind the Cyberattack Against Supermarket Freezers. It's Threatening Retaliation.
    6. 10d agoYahooPickupAre Our Medical Supplies Safe From Cyberattacks? What France’s Blood Bank Hack Means For The U.S.
    CyberFrance blames Iran for supermarket refrigeration cyberattacks and seeks EU sanctions97 linked

On the Hill

Congress, the White House and agencies
18

Ahead

Recent

Wednesday, Mar 18

Times ET

Contracts

Solicitations, SBIR topics, grants and awards
3

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy